Frequency of Null Allele of Human Leukocyte Antigen-G (HLA-G) Locus in Subjects to Recurrent Miscarriage

Overview

Journal Int J Reprod Biomed

Specialty Reproductive Medicine

Date 2016 Aug 16

PMID 27525330

Citations 5

Authors

Nazila Alizadeh

Elnaz Mosaferi

Laya Farzadi

Jafar Majidi

Amir Monfaredan

Bahman Yousefi

Behzad Baradaran

Affiliations

Soon will be listed here.

Abstract

Background: Human leukocyte antigen-G (HLA-G) is a non-classical class I molecule highly expressed by extravillous cytotrophoblast cells. Due to a single base pair deletion, its function can be compensated by other isoforms. Investigating the frequency of null allele in Recurrent Miscarriage (RM) subjects could be useful in understanding the relationship between frequency of this allele and RM in a given population.

Objective: This study aimed to determine the frequency of HLA-G*0105N null allele and its potential association with down-regulation of HLA-G in subjects with RM.

Materials And Methods: Western blotting was used to assess the level of HLA-G protein expression. For investigating the frequency of HLA-G*0105N null allele in RM subjects, PCR-RFLP method was used. Exon 3 of HLA-G gene was amplified by polymerase chain reaction (PCR). Subsequently, PpuM-1 enzyme was employed to digest the PCR products and fragments were analyzed using gel electrophoresis.

Results: Digestion using restriction enzyme showed the presence of heterozygous HLA-G*0105N null allele in 10% of the test population. Western blotting results confirmed the decrease in expression of HLA-G in the placental tissue of subjects with RM compared to subjects who could give normal birth.

Conclusion: The frequency of heterozygous HLA-G*0105N null allele was high to some extent in subjects with RM. The mutation rate in subjects suggested that there is a significant association between RM and frequency of mutations in this allele.

Citing Articles

Enhancing the Chemosensitivity of MKN-45 Gastric Cancer Cells to Docetaxel via Suppression: A Novel Therapeutic Strategy.

Aslan E, Akcali N, Yavas C, Eslamkhah S, Gur S, Batur L Life (Basel). 2025; 14(12.

PMID: 39768254 PMC: 11676808. DOI: 10.3390/life14121546.

HLA-G and single nucleotide polymorphism (SNP) associations with cancer in African populations: Implications in personal medicine.

Adolf I, Almars A, Dharsee N, Mselle T, Akan G, Nguma I Genes Dis. 2022; 9(5):1220-1233.

PMID: 35873024 PMC: 9293715. DOI: 10.1016/j.gendis.2021.06.004.

miR‑148a modulates the viability, migration and invasion of oral squamous cell carcinoma cells by regulating HLA‑G expression.

Zhang Y, Jin X, Wang J Mol Med Rep. 2019; 20(1):795-801.

PMID: 31180532 PMC: 6580030. DOI: 10.3892/mmr.2019.10280.

The Study of HLA-G Gene and Protein Expression in Patients with Recurrent Miscarriage.

Mosaferi E, Alizadeh Gharamaleki N, Farzadi L, Majidi J, Babaloo Z, Kazemi T Adv Pharm Bull. 2019; 9(1):70-75.

PMID: 31011560 PMC: 6468217. DOI: 10.15171/apb.2019.009.

Manzo G Front Cell Dev Biol. 2019; 7:20.

PMID: 30899759 PMC: 6416183. DOI: 10.3389/fcell.2019.00020.

References

Fournel S, Aguerre-Girr M, Huc X, Lenfant F, Alam A, Toubert A . Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol. 2000; 164(12):6100-4. DOI: 10.4049/jimmunol.164.12.6100. View

LeMaoult J, Krawice-Radanne I, Dausset J, Carosella E . HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Proc Natl Acad Sci U S A. 2004; 101(18):7064-9. PMC: 406466. DOI: 10.1073/pnas.0401922101. View

Suarez M, Morales P, Castro M, Fernandez V, Varela P, Alvarez M . A new HLA-G allele (HLA-G*0105N) and its distribution in the Spanish population. Immunogenetics. 1997; 45(6):464-5. DOI: 10.1007/s002510050235. View

Bainbridge D, Ellis S, Sargent I . HLA-G suppresses proliferation of CD4(+) T-lymphocytes. J Reprod Immunol. 2000; 48(1):17-26. DOI: 10.1016/s0165-0378(00)00070-x. View

Rahimi R, Zavaran Hosseini A, Yari F . Null allele frequencies at HLA-G locus in Iranian healthy subjects. Iran J Immunol. 2008; 5(4):207-11. DOI: IJIv5i4A3. View

Casro M, Morales P, Martinez-Laso J, Allende L, Varela P, Garcia-Berciano M . Homozygous HLA-G*0105N healthy individuals indicate that membrane-anchored HLA-G1 molecule is not necessary for survival. Tissue Antigens. 2000; 56(3):232-9. DOI: 10.1034/j.1399-0039.2000.560305.x. View

Hviid T, Meldgaard M, Sorensen S, Morling N . Polymorphism of exon 3 of the HLA-G gene. J Reprod Immunol. 1997; 35(1):31-42. DOI: 10.1016/s0165-0378(97)00051-x. View

Blaschitz A, Lenfant F, Mallet V, Hartmann M, Bensussan A, Geraghty D . Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G. Eur J Immunol. 1998; 27(12):3380-8. DOI: 10.1002/eji.1830271237. View

Miller S, Dykes D, Polesky H . A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16(3):1215. PMC: 334765. DOI: 10.1093/nar/16.3.1215. View

10.

Ober C, Aldrich C, Rosinsky B, Robertson A, Walker M, Willadsen S . HLA-G1 protein expression is not essential for fetal survival. Placenta. 1998; 19(2-3):127-32. DOI: 10.1016/s0143-4004(98)90000-5. View

11.

Fuzzi B, Rizzo R, Criscuoli L, Noci I, Melchiorri L, Scarselli B . HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol. 2002; 32(2):311-5. DOI: 10.1002/1521-4141(200202)32:2<311::AID-IMMU311>3.0.CO;2-8. View

12.

Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella E . Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A. 2001; 98(21):12150-5. PMC: 59783. DOI: 10.1073/pnas.201407398. View

13.

van der Ven K, Skrablin S, Engels G, Krebs D . HLA-G polymorphisms and allele frequencies in Caucasians. Hum Immunol. 1998; 59(5):302-12. DOI: 10.1016/s0198-8859(98)00021-4. View

14.

Gazit E, Slomov Y, Goldberg I, Brenner S, Loewenthal R . HLA-G is associated with pemphigus vulgaris in Jewish patients. Hum Immunol. 2004; 65(1):39-46. DOI: 10.1016/j.humimm.2003.09.019. View

15.

Ishitani A, Kishida M, Sageshima N, Yashiki S, Sonoda S, Hayami M . Re-examination of HLA-G polymorphism in African Americans. Immunogenetics. 1999; 49(9):808-11. DOI: 10.1007/s002510050555. View

16.

Donadi E, Castelli E, Arnaiz-Villena A, Roger M, Rey D, Moreau P . Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell Mol Life Sci. 2010; 68(3):369-95. PMC: 3021195. DOI: 10.1007/s00018-010-0580-7. View

17.

Matte C, LACAILLE J, Zijenah L, Ward B, Roger M . HLA-G and HLA-E polymorphisms in an indigenous African population. The ZVITAMBO Study Group. Hum Immunol. 2001; 61(11):1150-6. DOI: 10.1016/s0198-8859(00)00200-7. View

18.

Apps R, Gardner L, Moffett A . A critical look at HLA-G. Trends Immunol. 2008; 29(7):313-21. DOI: 10.1016/j.it.2008.02.012. View

19.

Bukur J, Rebmann V, Grosse-Wilde H, Luboldt H, Ruebben H, Drexler I . Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma. Cancer Res. 2003; 63(14):4107-11. View

20.

Sala F, Del Moral P, Pizzato N, Legrand-Abravanel F, Le Bouteiller P, Lenfant F . The HLA-G*0105N null allele induces cell surface expression of HLA-E molecule and promotes CD94/NKG2A-mediated recognition in JAR choriocarcinoma cell line. Immunogenetics. 2004; 56(9):617-24. DOI: 10.1007/s00251-004-0733-7. View